Friday, December 13, 2013
Add My Products
Cryopreservation, Cyrovials & Storage
Culture Kit for human ES/iPS cells
DataPaq™ Cryorack Scanner
DataPaq™ Deep Focus AV6 Scanner
DataPaq™ High Speed A4 Rack Scanner
DataPaq™ High Speed A6 Rack Scanner
DataPaq™ High Speed Single Tube Scanner
DataPaq™ Linear Rack Barcode Scanner
Freezing Medium for Human ES/iPS cells
Showing Results 1 - 10 of 13
Bridgepoint Development Capital to Acquire Quotient Clinical
Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.
UConn Chemist Discovers New Way to Stabilize Proteins
Discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.
'Smuggling' Drugs at the Cellular Level
Drexel researchers use ultrasound to deliver customized medication through the skin.
Nanosponge Vaccine Fights MRSA Toxins
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA could serve as a safe and effective vaccine against this toxin.
Drug Testing without the Pain at Queen’s
Microneedles on a sticking-plaster-like patch may be the painless and safe way doctors will test for drugs and some infections in the future.
UK Scientists to Begin Trial of Potential HIV Cure
Scientists and clinicians from five leading UK universities will begin a groundbreaking clinical trial next year to test a possible cure for HIV infection.
Key HIV Protein Structure Revealed
Researchers have developed a more detailed picture of the protein largely responsible for enabling HIV to enter human immune cells and cause infection.
New European Vaccine Initiative
Leading organisations have joined forces to rapidly assess and communicate the benefits and risks of vaccines.
Major Breakthrough in the Fight against Antibiotic Resistance
'Resistance breaker’ compounds have been described as the most important innovation in the discovery of new antibiotics since Alexander Fleming’s original breakthrough.
NIH Launches Trial of Investigational Genital Herpes Vaccine
Trial will test an investigational HSV-2 vaccine candidate, called HSV529.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.